Search Results - "Schoemaker, R C"

Refine Results
  1. 1

    Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert-Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study by Wirtz, PW, Verschuuren, JJ, Dijk, JG, Kam, ML, Schoemaker, RC, Hasselt, JGC, Titulaer, MJ, Tjaden, UR, Hartigh, J, Gerven, JMA

    Published in Clinical pharmacology and therapeutics (01-07-2009)
    “…3,4‐Diaminopyridine and pyridostigmine are widely used to treat Lambert–Eaton myasthenic syndrome (LEMS), either alone or in combination. 3,4‐Diaminopyridine…”
    Get full text
    Journal Article
  2. 2

    Effect of intrapulmonary tetrahydrocannabinol administration in humans by Zuurman, L., Roy, C., Schoemaker, RC, Hazekamp, A., den Hartigh, J., Bender, JCME, Verpoorte, R., Pinquier, JL, Cohen, AF, van Gerven, JMA

    Published in Journal of psychopharmacology (Oxford) (01-09-2008)
    “…This randomised, double-blind, placebo-controlled, cross-over study was designed to identify which pharmacodynamic parameters most accurately quantify the…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects by de Haas, SL, Schoemaker, RC, van Gerven, JMA, Hoever, P, Cohen, AF, Dingemanse, J

    Published in Journal of psychopharmacology (Oxford) (01-11-2010)
    “…Zolpidem is one of the most frequently prescribed hypnotics, as it is a very short-acting compound with relatively few side effects. Zolpidem’s short duration…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics and systemic endocrine effects of the phyto‐oestrogen 8‐prenylnaringenin after single oral doses to postmenopausal women by Rad, M., Hümpel, M., Schaefer, O., Schoemaker, R. C., Schleuning, W‐D., Cohen, A. F., Burggraaf, J.

    Published in British journal of clinical pharmacology (01-09-2006)
    “…Aims Pre‐clinical data suggest that the racemic phyto‐oestrogen 8‐prenylnaringenin (8‐PN) may have beneficial effects in postmenopausal women and may become an…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625 by Zuurman, L., Roy, C., Schoemaker, RC, Amatsaleh, A., Guimaeres, L., Pinquier, JL, Cohen, AF, van Gerven, JMA

    Published in Journal of psychopharmacology (Oxford) (01-03-2010)
    “…CB1 antagonists such as AVE1625 are potentially useful in the treatment of obesity, smoking cessation and cognitive impairment. Proof of pharmacological action…”
    Get full text
    Journal Article
  7. 7

    Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol by Liem-Moolenaar, M., Gray, FA, de Visser, SJ, Franson, KL, Schoemaker, RC, Schmitt, JAJ, Cohen, AF, van Gerven, JMA

    Published in Journal of psychopharmacology (Oxford) (01-01-2010)
    “…Central Nervous System (CNS) effects of talnetant, an NK-3 antagonist in development for schizophrenia, were compared to those of haloperidol and placebo. The…”
    Get full text
    Journal Article
  8. 8

    Ciclosporin kinetics in children after stem cell transplantation by Willemze, A. J., Cremers, S. C., Schoemaker, R. C., Lankester, A. C., Den Hartigh, J., Burggraaf, J., Vossen, J. M.

    Published in British journal of clinical pharmacology (01-10-2008)
    “…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Ciclosporin is an immunosuppressant drug that is commonly used as prophylaxis against graft‐versus‐host disease…”
    Get full text
    Journal Article
  9. 9

    Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers by Dumont, GJH, Schoemaker, RC, Touw, DJ, Sweep, FCGJ, Buitelaar, JK, van Gerven, JMA, Verkes, RJ

    Published in Journal of psychopharmacology (Oxford) (01-02-2010)
    “…In Western societies, a considerable percentage of young people use 3,4-methylenedioxymethamphetamine (MDMA or ‘ecstasy’). The use of alcohol (ethanol) in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology by Dumont, GJH, Kramers, C., Sweep, FCGJ, Willemsen, JJ, Touw, DJ, Schoemaker, RC, van Gerven, JMA, Buitelaar, JK, Verkes, RJ

    Published in Journal of psychopharmacology (Oxford) (01-02-2010)
    “…Alcohol is frequently used in combination with 3,4-methylenedioxymethamphetamine (MDMA). Both drugs affect cardiovascular function, hydration and temperature…”
    Get full text
    Journal Article
  12. 12

    Pharmacokinetics of rectal tramadol in postoperative paediatric patients by Zwaveling, J., Bubbers, S., van Meurs, A.H.J., Schoemaker, R.C., van Heel, I. Ruijs-Dudok, Vermeij, P., Burggraaf, J.

    Published in British journal of anaesthesia : BJA (01-08-2004)
    “…Postoperative analgesia in children may be improved by using tramadol. The pharmacokinetics of rectal tramadol in young children were therefore investigated…”
    Get full text
    Journal Article
  13. 13

    Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy by Broeyer, F. J. F., Osanto, S., Ritsema van Eck, H. J., van Steijn, A. Q. M. J., Ballieux, B. E. P. B., Schoemaker, R. C., Cohen, A. F., Burggraaf, J.

    “…Introduction The clinical assessment of the myocardial damage caused by anthracyclin (ANT)-therapy is difficult. Therefore a study was performed to evaluate…”
    Get full text
    Journal Article
  14. 14

    Sympathovagal imbalance in hyperthyroidism by Burggraaf, J, Tulen, J H, Lalezari, S, Schoemaker, R C, De Meyer, P H, Meinders, A E, Cohen, A F, Pijl, H

    “…We assessed sympathovagal balance in thyrotoxicosis. Fourteen patients with Graves' hyperthyroidism were studied before and after 7 days of treatment with…”
    Get more information
    Journal Article
  15. 15

    Cognitive performance and serotonergic function in users of ecstasy by VERKES, Robbert J, GIJSMAN, Harm J, COHEN, Adam F, PIETERS, Monique S. M, SCHOEMAKER, Rik C, DE VISSER, Saco, KUIJPERS, Monique, PENNINGS, Ed J. M, DE BRUIN, Dick, VAN DE WIJNGAART, Govert, VAN GERVEN, Joop M. A

    Published in Psychopharmacologia (01-01-2001)
    “…(+/-) 3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") has been shown to cause long term damage to serotonergic cerebral neurons in animals. The…”
    Get full text
    Journal Article
  16. 16

    The influence of cisapride and clarithromycin on QT intervals in healthy volunteers by Haarst, Aernout D., van't Klooster, Gerben A. E., Gerven, Joop M. A., Schoemaker, Rik C., Oene, Joop C., Burggraaf, Jacobus, Coene, Marie‐Claire, Cohen, Adam F.

    Published in Clinical pharmacology and therapeutics (01-11-1998)
    “…Objective Recently a few cases of long QT syndrome were reported during treatment with cisapride. In most of these cases, risk factors for cardiac arrhythmias…”
    Get full text
    Journal Article
  17. 17

    Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa by Smarius, LJCA, Jacobs, GE, Hoeberechts-Lefrandt, DHM, de Kam, ML, van der Post, JP, de Rijk, R, van Pelt, J, Schoemaker, RC, Zitman, FG, van Gerven, JMA, Gijsman, HJ

    Published in Journal of psychopharmacology (Oxford) (01-06-2008)
    “…5-hydroxytryptophan (5-HTP) is a direct 5-hydroxytryptamine (5-HT) precursor used to assess central serotonergic function. Its use has been limited by a narrow…”
    Get full text
    Journal Article
  18. 18

    Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant by Hoever, P, Haas, S, Winkler, J, Schoemaker, R C, Chiossi, E, Gerven, J, Dingemanse, J

    Published in Clinical pharmacology and therapeutics (01-05-2010)
    “…Almorexant, a dual orexin receptor antagonist potentially representing a new class of sleep‐promoting compounds, was administered in an ascending single‐dose…”
    Get full text
    Journal Article
  19. 19

    Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics by KREILGAARD, Mads, KEMME, Michiel J. B, BURGGRAAF, Jacobus, SCHOEMAKER, Rik C, COHEN, Adam F

    Published in Pharmaceutical research (01-05-2001)
    “…The aim of the study was to investigate the cutaneous bioequivalence of a lipophilic model drug (lidocaine) applied in a novel topical microemulsion vehicle,…”
    Get full text
    Journal Article
  20. 20

    High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection by Weijtens, Olga, Feron, Eric J, Schoemaker, Rik C, Cohen, Adam F, Lentjes, Eef G.W.M, Romijn, Fred P.H.T.M, van Meurs, Jan C

    Published in American journal of ophthalmology (01-08-1999)
    “…PURPOSE: To determine the dexamethasone concentration in aqueous, vitreous, and serum of patients after a subconjunctival injection with dexamethasone disodium…”
    Get full text
    Journal Article